Targeting Myeloid-Derived Suppressor Cells Is a Novel Strategy for Anti-Psoriasis Therapy
Psoriasis is a common immune-mediated, chronic inflammatory genetic-related disease that affects patients’ quality of life. Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of progenitor and immature myeloid cells which are expanded in psoriatic skin lesions and peripheral blo...
Saved in:
Main Authors: | Chao Chen, Lirong Tan, Wu Zhu, Li Lei, Yehong Kuang, Panpan Liu, Jie Li, Xiang Chen, Cong Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2020/8567320 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy
by: Shuyan He, et al.
Published: (2025-01-01) -
Immunosuppressive Role of Myeloid-Derived Suppressor Cells and Therapeutic Targeting in Lung Cancer
by: Jie Ma, et al.
Published: (2018-01-01) -
Myeloid-Derived Suppressor Cells Participate in Preventing Graft Rejection
by: Yan Wang, et al.
Published: (2012-01-01) -
Role of T Regulatory Cells and Myeloid-Derived Suppressor Cells in COVID-19
by: Alhasan Alsalman, et al.
Published: (2022-01-01) -
The Crosstalk between Myeloid Derived Suppressor Cells and Immune Cells: To Establish Immune Tolerance in Transplantation
by: Chao Zhang, et al.
Published: (2016-01-01)